中外医疗
中外醫療
중외의료
CHINA FOREIGN MEDICAL TREATMENT
2015年
10期
59-60
,共2页
联合化疗方案%骨髓增生异常%疗效
聯閤化療方案%骨髓增生異常%療效
연합화료방안%골수증생이상%료효
Combining chemotherapy project%Myelodysplastic syndrome%Efficacy
目的:整合分析在治疗MDS和AML中采用联合化疗的方法,根据总有效率探讨其在临床中的应用成效。方法将随机选择的来该院治疗的74例病患者按照1∶1比例分为对照组和治疗组,每组37例,对照组使用单一5-杂氮-2’-脱氧胞苷治疗,治疗组采取联合化疗方案治疗,分析计量资料后对比两组的医治结果。结果对照组的总有效率为29.7%,低于治疗组51.3%的总有效率21%,显示联合化疗法医疗成效显著(P<0.05)。结论联合化疗法在治疗MDS和AML中可以分明改善病人病情,该试验所用方法可以成为该病临床治疗的精良参照。
目的:整閤分析在治療MDS和AML中採用聯閤化療的方法,根據總有效率探討其在臨床中的應用成效。方法將隨機選擇的來該院治療的74例病患者按照1∶1比例分為對照組和治療組,每組37例,對照組使用單一5-雜氮-2’-脫氧胞苷治療,治療組採取聯閤化療方案治療,分析計量資料後對比兩組的醫治結果。結果對照組的總有效率為29.7%,低于治療組51.3%的總有效率21%,顯示聯閤化療法醫療成效顯著(P<0.05)。結論聯閤化療法在治療MDS和AML中可以分明改善病人病情,該試驗所用方法可以成為該病臨床治療的精良參照。
목적:정합분석재치료MDS화AML중채용연합화료적방법,근거총유효솔탐토기재림상중적응용성효。방법장수궤선택적래해원치료적74례병환자안조1∶1비례분위대조조화치료조,매조37례,대조조사용단일5-잡담-2’-탈양포감치료,치료조채취연합화료방안치료,분석계량자료후대비량조적의치결과。결과대조조적총유효솔위29.7%,저우치료조51.3%적총유효솔21%,현시연합화요법의료성효현저(P<0.05)。결론연합화요법재치료MDS화AML중가이분명개선병인병정,해시험소용방법가이성위해병림상치료적정량삼조。
Objective According to the total efficiencyand to discuss the effect in clinical practice of the method which combined with chemotherapy in the treatment of the groups with high-risk myelodysplastic syndrome and acute myeloid leukemia (MDS/AML). Methods our hospital’s 74 cases with MDS or AML by selecting randomly,according to the 1 to 1 ratio divided into the control group and treated group,37 cases in each group. The control group using a single 5-aza-2'-deoxycytidine treatment,the treatment group taking combining chemotherapy treatment. Comparing the two groups curative efficacy by analyzing the measurement data.Results The total effective rate of treatment group was 51.3%,while the control group’s total efficiency is 29.7%, was 21%lower,showed that the combining chemotherapy treatment have the significant medical results (P<0.05).Conclusion Using combining chemotherapy project treat MDS and AML can significantly improve the patient's condition, method used in this experiment can be good reference to the clinical treatment of the disease.